Comments
Loading...

Privia Health Gr Analyst Ratings

PRVANASDAQ
Logo brought to you by Benzinga Data
$22.00
0.000.00%
At close: -
$22.00
0.000.00%
After Hours: 4:34 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$51.00
Lowest Price Target1
$20.00
Consensus Price Target1
$31.50

Privia Health Gr Analyst Ratings and Price Targets | NASDAQ:PRVA | Benzinga

Privia Health Group Inc has a consensus price target of $31.5 based on the ratings of 28 analysts. The high is $51 issued by Guggenheim on August 12, 2022. The low is $20 issued by Evercore ISI Group on July 9, 2024. The 3 most-recent analyst ratings were released by JP Morgan, Barclays, and JMP Securities on May 28, 2025, May 27, 2025, and April 28, 2025, respectively. With an average price target of $28.33 between JP Morgan, Barclays, and JMP Securities, there's an implied 28.79% upside for Privia Health Group Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
4
Jan
3
Feb
1
Mar
3
1
Apr
1
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JP Morgan
Barclays
JMP Securities
Baird
Truist Securities

1calculated from analyst ratings

Analyst Ratings for Privia Health Gr

Buy NowGet Alert
05/28/2025Buy Now45.45%JP Morgan
Lisa Gill55%
$29 → $32MaintainsOverweightGet Alert
05/27/2025Buy Now9.09%Barclays
Andrew Mok57%
$23 → $24MaintainsEqual-WeightGet Alert
04/28/2025Buy Now31.82%JMP Securities
Constantine Davides42%
$29 → $29ReiteratesMarket Outperform → Market OutperformGet Alert
04/15/2025Buy Now18.18%Baird
Michael Ha37%
$24 → $26MaintainsOutperformGet Alert
04/10/2025Buy Now4.55%Barclays
Andrew Mok57%
$21 → $23MaintainsEqual-WeightGet Alert
04/10/2025Buy Now27.27%Truist Securities
Jailendra Singh38%
$27 → $28MaintainsBuyGet Alert
04/10/2025Buy Now36.36%Needham
Matthew Sheerin75%
$30 → $30ReiteratesBuy → BuyGet Alert
03/21/2025Buy Now36.36%Needham
Ryan MacDonald63%
$30 → $30ReiteratesBuy → BuyGet Alert
02/28/2025Buy Now31.82%Citizens Capital Markets
Constantine Davides42%
$26 → $29MaintainsMarket OutperformGet Alert
02/28/2025Buy Now36.36%Canaccord Genuity
Richard Close46%
$29 → $30MaintainsBuyGet Alert
02/28/2025Buy Now81.82%Piper Sandler
Sean Wieland44%
$25 → $40MaintainsOverweightGet Alert
02/28/2025Buy Now36.36%Needham
Ryan MacDonald63%
$25 → $30MaintainsBuyGet Alert
02/14/2025Buy Now18.18%JMP Securities
Constantine Davides42%
$26 → $26MaintainsMarket OutperformGet Alert
01/15/2025Buy Now13.64%Needham
Ryan MacDonald63%
$25 → $25ReiteratesBuy → BuyGet Alert
01/10/2025Buy Now13.64%Needham
Matthew Sheerin75%
→ $25Initiates → BuyGet Alert
01/07/2025Buy Now18.18%Stephens & Co.
Jeff Garro37%
$26 → $26ReiteratesOverweight → OverweightGet Alert
01/02/2025Buy Now18.18%Stephens & Co.
Jeff Garro37%
$26 → $26ReiteratesOverweight → OverweightGet Alert
12/16/2024Buy Now13.64%Macquarie
Tao Qiu52%
→ $25Initiates → OutperformGet Alert
11/29/2024Buy Now27.27%JP Morgan
Lisa Gill55%
$27 → $28MaintainsOverweightGet Alert
11/08/2024Buy Now-4.55%Barclays
Andrew Mok57%
$19 → $21MaintainsEqual-WeightGet Alert
11/08/2024Buy Now22.73%Truist Securities
Jailendra Singh38%
$24 → $27MaintainsBuyGet Alert
10/11/2024Buy Now4.55%Keybanc
Matthew Gillmor65%
→ $23Initiates → OverweightGet Alert
08/26/2024Buy Now9.09%Baird
Michael Ha37%
$23 → $24MaintainsOutperformGet Alert
08/14/2024Buy Now27.27%RBC Capital
Sean Dodge47%
$28 → $28ReiteratesOutperform → OutperformGet Alert
07/09/2024Buy Now-9.09%Evercore ISI Group
Elizabeth Anderson48%
$23 → $20MaintainsOutperformGet Alert
05/30/2024Buy Now4.55%Baird
Michael Ha37%
→ $23Initiates → OutperformGet Alert
05/20/2024Buy Now-13.64%Barclays
Andrew Mok57%
$22 → $19MaintainsEqual-WeightGet Alert
05/15/2024Buy Now9.09%Truist Securities
Jailendra Singh38%
$28 → $24MaintainsBuyGet Alert
05/10/2024Buy Now18.18%Canaccord Genuity
Richard Close46%
$37 → $26MaintainsBuyGet Alert
05/01/2024Buy Now9.09%Stifel
Craig Jones46%
$28 → $24MaintainsBuyGet Alert
04/22/2024Buy Now13.64%Citigroup
Daniel Grosslight44%
→ $25Initiates → BuyGet Alert
03/19/2024Buy Now68.18%Canaccord Genuity
Richard Close46%
$41 → $37MaintainsBuyGet Alert
03/06/2024Buy Now36.36%JP Morgan
Lisa Gill55%
$38 → $30MaintainsOverweightGet Alert
03/06/2024Buy NowBarclays
Andrew Mok57%
→ $22Initiates → Equal-WeightGet Alert
03/01/2024Buy Now31.82%UBS
Andrew Mok57%
$31 → $29MaintainsBuyGet Alert
03/01/2024Buy Now18.18%TD Cowen
Gary Taylor58%
$30 → $26MaintainsOutperformGet Alert
02/29/2024Buy Now27.27%Truist Securities
Jailendra Singh38%
$32 → $28MaintainsBuyGet Alert
02/28/2024Buy Now13.64%Evercore ISI Group
Elizabeth Anderson48%
$26 → $25MaintainsOutperformGet Alert
02/22/2024Buy Now-4.55%B of A Securities
Adam Ron45%
$27 → $21DowngradeBuy → NeutralGet Alert
12/06/2023Buy Now22.73%JMP Securities
Constantine Davides42%
→ $27Initiates → Market OutperformGet Alert
11/17/2023Buy Now72.73%JP Morgan
Lisa Gill55%
$43 → $38MaintainsOverweightGet Alert
08/18/2023Buy Now45.45%UBS
Andrew Mok57%
$35 → $32MaintainsBuyGet Alert
08/15/2023Buy Now59.09%TD Cowen
Gary Taylor58%
$44 → $35MaintainsOutperformGet Alert
06/22/2023Buy Now86.36%Credit Suisse
Jonathan Yon51%
→ $41ReiteratesOutperform → OutperformGet Alert
06/13/2023Buy Now54.55%Evercore ISI Group
Elizabeth Anderson48%
→ $34Initiates → OutperformGet Alert
05/08/2023Buy Now86.36%Credit Suisse
Jonathan Yon51%
→ $41Reiterates → OutperformGet Alert
04/12/2023Buy Now50%Stephens & Co.
Jeff Garro37%
→ $33Initiates → OverweightGet Alert
03/10/2023Buy Now63.64%RBC Capital
Sean Dodge47%
→ $36Initiates → OutperformGet Alert
03/07/2023Buy Now86.36%Credit Suisse
Jonathan Yong65%
→ $41Reiterates → OutperformGet Alert
02/03/2023Buy Now45.45%Goldman Sachs
Jamie Perse63%
→ $32Initiates → BuyGet Alert
12/09/2022Buy Now27.27%Stifel
Craig Jones46%
→ $28Initiates → BuyGet Alert
12/08/2022Buy Now36.36%UBS
Andrew Mok57%
→ $30Initiates → BuyGet Alert
11/11/2022Buy Now95.45%Canaccord Genuity
Richard Close46%
$50 → $43MaintainsBuyGet Alert
11/11/2022Buy Now77.27%SVB Leerink
Whit Mayo67%
$46 → $39MaintainsOutperformGet Alert
09/07/2022Buy Now145.45%Truist Securities
Jailendra Singh38%
$48 → $54Assumes → BuyGet Alert
08/25/2022Buy Now127.27%Canaccord Genuity
Richard Close46%
$45 → $50MaintainsBuyGet Alert
08/12/2022Buy Now118.18%Truist Securities
David Macdonald65%
$40 → $48MaintainsBuyGet Alert
08/12/2022Buy Now131.82%Guggenheim
Sandy Draper73%
$36 → $51MaintainsBuyGet Alert
08/12/2022Buy Now86.36%Credit Suisse
Nick Giovacchini49%
$33 → $41MaintainsOutperformGet Alert
08/12/2022Buy Now100%Cowen & Co.
Gary Taylor58%
$35 → $44MaintainsOutperformGet Alert
08/12/2022Buy Now109.09%SVB Leerink
Whit Mayo67%
$33 → $46MaintainsOutperformGet Alert
07/14/2022Buy Now81.82%Truist Securities
David Macdonald65%
$36 → $40MaintainsBuyGet Alert

FAQ

Q

What is the target price for Privia Health Gr (PRVA) stock?

A

The latest price target for Privia Health Gr (NASDAQ:PRVA) was reported by JP Morgan on May 28, 2025. The analyst firm set a price target for $32.00 expecting PRVA to rise to within 12 months (a possible 45.45% upside). 25 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Privia Health Gr (PRVA)?

A

The latest analyst rating for Privia Health Gr (NASDAQ:PRVA) was provided by JP Morgan, and Privia Health Gr maintained their overweight rating.

Q

When was the last upgrade for Privia Health Gr (PRVA)?

A

There is no last upgrade for Privia Health Gr

Q

When was the last downgrade for Privia Health Gr (PRVA)?

A

The last downgrade for Privia Health Group Inc happened on February 22, 2024 when B of A Securities changed their price target from $27 to $21 for Privia Health Group Inc.

Q

When is the next analyst rating going to be posted or updated for Privia Health Gr (PRVA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Privia Health Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Privia Health Gr was filed on May 28, 2025 so you should expect the next rating to be made available sometime around May 28, 2026.

Q

Is the Analyst Rating Privia Health Gr (PRVA) correct?

A

While ratings are subjective and will change, the latest Privia Health Gr (PRVA) rating was a maintained with a price target of $29.00 to $32.00. The current price Privia Health Gr (PRVA) is trading at is $22.00, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch